Research Disclosures & Disclaimers

This website contains disclosures and disclaimers related to
published UBS Global Research products, including those related to
regulation, potential conflicts of interest as well as those provided
by third-party data providers describing limitations on use of their
products.

LBX Pharmacy Chain (603883.SS)*

UBS Rating and Price Target History Chart

Line chart explaining Price target vs Stock Price is described in below table

EQ Rating & Price Target Table

Date	Stock Price (Rmb)	Price Target (Rmb)	Rating
2022-02-28	25.15	48.225	Buy
2022-05-25	23.55	28.077	Buy
2022-08-30	25.44	30.769	Buy
2022-10-31	27.03	33.846	Buy
2023-05-04	27.42	35.385	Buy
2023-09-01	19.55	31.923	Buy
2024-04-30	25.75	32.30	Buy
2024-10-08	18.74	22.50	Buy
2024-10-30	15.88	21.00	Buy
2025-04-30	20.15	22.50	Buy

Note : Historical Price Targets have been adjusted to account for any stock splits, rights issues and/or dividends which may have occurred for this security. Not Priced: Stock was not priced on the given date. No Rating: Issuer was not rated by UBS on the given day. No Price Target: For this issuer no Price Target was set by UBS on the given day. Issuers with an EQ Rating & Price Target Table are covered by UBS-IB Equity Research Analysts. Issuers without an EQ Rating & Price Target Table are not single stock covered.

* Issuers marked with an asterisk are covered by UBS-IB Equity Research Analysts. Issuers without an asterisk are not single stock covered.